Takeda Pharmaceutical Company Limited Stock Forecast
Takeda Pharmaceutical Company Limited stock upgraded to Sell Candidate.
(Updated on Apr 26, 2024)
The Takeda Pharmaceutical Company Limited stock price fell by -0.306% on the last day (Friday, 26th Apr 2024) from $13.07 to $13.03. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 0.577% from a day low at $13.01 to a day high of $13.08. The price has been going up and down for this period, and there has been a -2.54% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -439 thousand shares and in total, 1 million shares were bought and sold for approximately $15.80 million.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.37% during the next 3 months and, with a 90% probability hold a price between $11.41 and $12.72 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
TAK Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Takeda Pharmaceutical Company Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $13.21 and $13.82. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 07, 2024, and so far it has fallen -12.31%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Takeda Pharmaceutical Company Limited stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.0750 between high and low, or 0.577%. For the last week the stock has had daily average volatility of 0.85%.
Takeda Pharmaceutical Company Limited is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (TAK) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect Takeda Pharmaceutical Company Limited to open at $13.04, and during the day (based on 14 day Average True Range), to move between $12.87 and $13.19, which gives a possible trading interval of +/-$0.160 (+/-1.23%) up or down from last closing price. If Takeda Pharmaceutical Company Limited takes out the full calculated possible swing range there will be an estimated 2.46% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $13.92, some $0.89 (6.83%) from the current price of $13.03, our system finds the risk reward not very attractive.
Is Takeda Pharmaceutical Company Limited stock A Buy?
Takeda Pharmaceutical Company Limited holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score: -3.065 Sell Candidate Upgraded
Predicted Opening Price for Takeda Pharmaceutical Company Limited of Monday, April 29, 2024
| Fair opening price April 29, 2024 | Current price |
|---|---|
| $13.04 ( 0.0640%) | $13.03 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for TAK
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 13.11 | 0.640 % | |
| R2 | 13.08 | 0.420 % | ||
| R1 | 13.07 | 0.284 % | ||
| Current price: | 13.03 | |||
| Support | S1 | 13.01 | -0.156 % | |
| S2 | 12.99 | -0.292 % | ||
| S3 | 12.96 | -0.512 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 14.62 | 12.20 % | |
| R2 | 14.28 | 9.59 % | ||
| R1 | 13.92 | 6.83 % | ||
| Current price | 13.03 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
TAK Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Mar 27, 2024 | Mar 27, 2024 | Mar 27, 2024 | $0.301 | 2.12% |
| 2 | Sep 13, 2023 | Sep 28, 2023 | Dec 11, 2023 | $0.260 | 1.85% |
| 3 | Sep 13, 2022 | Sep 29, 2022 | Dec 12, 2022 | $0.270 | 1.81% |
| 4 | Sep 29, 2021 | Sep 29, 2021 | Dec 13, 2021 | $0.397 | 2.94% |
| 5 | Mar 15, 2021 | Mar 30, 2021 | Jul 12, 2021 | $0.407 | 2.44% |
FAQ
Click here for our free guide on how to buy Takeda Pharmaceutical Company Limited Stock.
